Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] SK Square (402340) – New Facility Investment / 2026-07-22

Posted on July 22, 2026July 31, 2026 By K-STOCK Editor No Comments on [Disclosure] SK Square (402340) – New Facility Investment / 2026-07-22

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

SK Square’s major subsidiary, SK Hynix, resolved to increase its capital investment for the construction of Cheongju P&T7 to KRW 7.0931T (5.88% of equity) to address global AI memory demand.

📊 [Summary of Key Disclosure Facts & Figures]

1. Investment Overview & Type

  • Disclosure Type: New Facility Investment (Major Management Matter of Subsidiary)
  • Subsidiary Name: SK Hynix Inc.
  • Investment Category: New Facility Investment
  • Target Facility: Construction of Cheongju P&T7

2. Investment Details (Unit: KRW, %)

  • Investment Amount: KRW 7,093,100,000,000 (approx. KRW 7.09T)
  • Equity: KRW 120,666,750,890,698 (based on the latest fiscal year-end consolidated financial statement)
  • Investment Ratio to Equity: 5.88%
  • Large Corporation Status: Applicable

3. Investment Purpose & Schedule

  • Purpose: Securing Cheongju production base to respond to global AI memory demand
  • Investment Period: 2025-11-26 ~ 2032-12-31

4. Board Resolution Date

  • Resolution Date: 2026-07-22 (6 Independent Directors attended, 0 absent)

5. Other Key Investment Notes

  • Regarding the construction of Cheongju P&T7 Fab, the 8th Board of Directors meeting in 2026 (2026.07.22) resolved to increase the investment amount to handle production expansion and shorten the Clean Room opening schedule.
  • Investment amount and scheduled completion date are subject to change during the execution process based on shifts in business conditions.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of P&T7 Construction Progress and Future CAPEX Execution

This filing notifies a major management event of a subsidiary regarding SK Hynix’s increased investment in the Cheongju P&T7 facility. Tracking quarterly CAPEX deployment alongside the accelerated Clean Room opening schedule is relevant for monitoring capital allocation and production capacity expansion. Specific details can be verified through upcoming quarterly/half-yearly/annual financial reports and subsequent official filings by SK Hynix and SK Square.

📢 Disclaimer & Source Information

Source: This content was newly structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Disclaimer: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] SK Hynix (000660) – Clarification Regarding Rumors or Reports / 2026-07-22
Next Post: [Disclosure] SK Square (402340) – Decision on Stock Retirement / 2026-07-22

Related Posts

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Ulcerative Colitis) / 2024-06-18 Disclosures
[Disclosure] Samsung Biologics (207940) – (Correction) Major Management Matters Related to Investment Decisions / 2024-03-27 Disclosures
[Disclosure] Hanwha Aerospace (012450) – FY2023 Q4 and Annual Consolidated Preliminary Earnings Release (Annual Revenue KRW 9.37T, Operating Profit KRW 704.9B) Disclosures
[Disclosure] Samsung Electro-Mechanics (009150) – Investor Relations (IR) Schedule Announcement / 2024-10-10 Semiconductors
[Disclosure] Hanwha Systems (272210) – Signs KRW 163.9B Supply Contract with KAI for LAH 2nd Mass Production Disclosures
[Disclosure] Hanwha Systems (272210) Signs KRW 859.3B Defense Supply Contract with LIG Nex1 for MFR Production (Cheongung-II Export to Iraq) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme